Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (131-140 of 348) with videos related to

Pageof 35
Sort By:
Nature|December 17, 2008
Enhancing SIV-specific immunity in vivo by PD-1 blockadeVijayakumar Velu, Kehmia Titanji, Baogong Zhu, et al.
Journal for Immunotherapy of Cancer|February 8, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumabKathleen M Mahoney, Petra Ross-Macdonald, Long Yuan, et al.
The Journal of Clinical Investigation|July 17, 2003
The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunityHiroshi Harada, Alan D Salama, Masayuki Sho, et al.
Immunity|May 18, 2019
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 TherapyMelvyn T Chow, Aleksandra J Ozga, Rachel L Servis, et al.
Journal for Immunotherapy of Cancer|August 17, 2019
The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, et al.
Plos Pathogens|February 28, 2009
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockadeNobuhiro Nakamoto, Hyosun Cho, Abraham Shaked, et al.
The Journal of Experimental Medicine|April 12, 2006
Tissue expression of PD-L1 mediates peripheral T cell toleranceMary E Keir, Spencer C Liang, Indira Guleria, et al.
NPJ Breast Cancer|July 20, 2017
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in <i>BRCA1</i>-associated and sporadic triple-negative breast cancerNadine Tung, Judy E Garber, Michele R Hacker, et al.
Journal of Virology|December 20, 2013
Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functionsFilippos Porichis, Meghan G Hart, Jennifer Zupkosky, et al.
Nature Immunology|October 14, 2003
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral toleranceCatherine A Sabatos, Sumone Chakravarti, Eugene Cha, et al.
Pageof 35

Showing results (131-140 of 348) with videos related to

Sort By:
Pageof 35
Nature|December 17, 2008
Enhancing SIV-specific immunity in vivo by PD-1 blockadeVijayakumar Velu, Kehmia Titanji, Baogong Zhu, et al.
Journal for Immunotherapy of Cancer|February 8, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumabKathleen M Mahoney, Petra Ross-Macdonald, Long Yuan, et al.
The Journal of Clinical Investigation|July 17, 2003
The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunityHiroshi Harada, Alan D Salama, Masayuki Sho, et al.
Immunity|May 18, 2019
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 TherapyMelvyn T Chow, Aleksandra J Ozga, Rachel L Servis, et al.
Journal for Immunotherapy of Cancer|August 17, 2019
The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, et al.
Plos Pathogens|February 28, 2009
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockadeNobuhiro Nakamoto, Hyosun Cho, Abraham Shaked, et al.
The Journal of Experimental Medicine|April 12, 2006
Tissue expression of PD-L1 mediates peripheral T cell toleranceMary E Keir, Spencer C Liang, Indira Guleria, et al.
NPJ Breast Cancer|July 20, 2017
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in <i>BRCA1</i>-associated and sporadic triple-negative breast cancerNadine Tung, Judy E Garber, Michele R Hacker, et al.
Journal of Virology|December 20, 2013
Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functionsFilippos Porichis, Meghan G Hart, Jennifer Zupkosky, et al.
Nature Immunology|October 14, 2003
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral toleranceCatherine A Sabatos, Sumone Chakravarti, Eugene Cha, et al.
Pageof 35